Latest News

ToxStrategies at ACT 2016 – Baltimore, MD

ToxStrategies will be represented at the upcoming American College of Toxicology (ACT) meeting in Baltimore, Maryland (November 6-9, 2016) by Dr. Andrea Weir and Dr. Gary Chellman.

Dr. Weir and Dr. Chellman are Senior Scientists in ToxStrategies’ Biopharmaceutical/Pharmaceutical Practice and have extensive expertise assisting clients with a wide array of issues related to nonclinical safety assessments for novel small molecule and biological products, including general toxicology and reproductive toxicology.  ToxStrategies’ scientists have worked at the FDA, as well as in the biopharmaceutical and pharmaceutical industries, and are uniquely suited to assist clients with complicated scientific, regulatory, and strategic challenges that arise during the nonclinical development of drug candidates.

Please contact Dr. Weir ( or Dr. Chellman ( if you would like to arrange to meet with them at ACT.